Endothelial cell injury in venule and capillary induced by contrast ultrasonography.

The aim of the present study was to test the hypothesis that microvascular endothelial cells (EC) are subject to the bioeffects induced by contrast ultrasound (US) because of their proximity to the circulating microbubbles. We examined EC injury in each microvessel section (arteriole, capillary or venule) in rat mesenteries among the following five groups: three controls (sham operation, microbubble injection alone, US exposure with saline injection), and two contrast-US groups (US exposure at a 1-Hz or 30-Hz frame rate with microbubble injection). Propidium iodide (PI), a fluorescent indicator of cell injury, was employed to visualize impaired EC. PI-positive nuclei were equally few among the three controls. Contrast-US increased PI-positive cells in capillaries (1-Hz frame rate, 2.4 +/- 2.2 cells per 0.1-mm vessel length, p = 0.09; 30-Hz frame rate, 4.3 +/- 1.8 cells, p < 0.01) and in venules (1-Hz frame rate, 4.1 +/- 2.5 cells, p < 0.05; 30-Hz frame rate, 13.8 +/- 3.6 cells, p < 0.01) compared with sham operation (0.10 +/- 0.22 cells). The finding indicates that diagnostic contrast US potentially causes EC injury, particularly in venules and capillaries.

[1]  E. Endl,et al.  Cell-type-specific response to shock waves of suspended or pelleted cells as analysed by flow cytometry or electrical cell volume determination. , 1996, Ultrasound in medicine & biology.

[2]  S S Segal,et al.  The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. , 1989, Circulation research.

[3]  A. Ham,et al.  Ham's histology , 1987 .

[4]  D. Miller,et al.  Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents. , 1998, Ultrasound in medicine & biology.

[5]  P. Colonna,et al.  Clinical applications of contrast echocardiography. , 2001, American heart journal.

[6]  R S Meltzer,et al.  Hemolysis in vivo from exposure to pulsed ultrasound. , 1997, Ultrasound in medicine & biology.

[7]  G. Schmid-Schönbein,et al.  Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[8]  K. Takayama,et al.  Dynamic behavior of bubbles during extracorporeal shock-wave lithotripsy. , 1998, Ultrasound in medicine & biology.

[9]  Douglas L. Miller,et al.  Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. , 2000, Ultrasound in medicine & biology.

[10]  Morton W. Miller,et al.  A review of in vitro bioeffects of inertial ultrasonic cavitation from a mechanistic perspective. , 1996, Ultrasound in medicine & biology.

[11]  C. Cox,et al.  A comparison of the hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations. , 2001, Ultrasound in medicine & biology.

[12]  W. J. Lorenz,et al.  A new method of quantitative cavitation assessment in the field of a lithotripter. , 1996, Ultrasound in medicine & biology.

[13]  D S Segar,et al.  Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. , 1998, Journal of the American College of Cardiology.

[14]  D. Miller,et al.  The influence of ultrasound frequency and gas-body composition on the contrast agent-mediated enhancement of vascular bioeffects in mouse intestine. , 2000, Ultrasound in medicine & biology.

[15]  D. Miller,et al.  Gas-body-based contrast agent enhances vascular bioeffects of 1.09 MHz ultrasound on mouse intestine. , 1998, Ultrasound in medicine & biology.

[16]  M. Miller,et al.  Erosion of artificial endothelia in vitro by pulsed ultrasound: acoustic pressure, frequency, membrane orientation and microbubble contrast agent dependence. , 1999, Ultrasound in medicine & biology.

[17]  D. Cumberland,et al.  Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. , 1999, Circulation.

[18]  J. Weiss,et al.  Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. , 1998, Journal of the American College of Cardiology.

[19]  F. Hofstaedter,et al.  Determination of the energy-dependent extent of vascular damage caused by high-energy shock waves in an umbilical cord model , 2004, Urological Research.

[20]  B. Lüderitz,et al.  Real‐Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power , 1999, Echocardiography.

[21]  H. Dittrich,et al.  Detection of angiographically significant coronary artery disease with accelerated intermittent imaging after intravenous administration of ultrasound contrast material. , 2000, American heart journal.

[22]  F Forsberg,et al.  Clinical applications of ultrasound contrast agents. , 1998, Ultrasonics.

[23]  D. Miller,et al.  Lysis and sonoporation of epidermoid and phagocytic monolayer cells by diagnostic ultrasound activation of contrast agent gas bodies. , 2001, Ultrasound in medicine & biology.

[24]  P. Zhong,et al.  Dynamics of bubble oscillation in constrained media and mechanisms of vessel rupture in SWL. , 2001, Ultrasound in medicine & biology.

[25]  F J Ten Cate,et al.  Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. , 1990, Journal of the American College of Cardiology.

[26]  Stefan Nilsson,et al.  The Circulatory System , 1983 .

[27]  Z. Darżynkiewicz,et al.  Features of apoptotic cells measured by flow cytometry. , 1992, Cytometry.

[28]  D. Kitzman,et al.  Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease. , 2000, American heart journal.

[29]  Feng Yan,et al.  BR1: A New Ultrasonographic Contrast Agent Based on Sulfur Hexafluoride-Filled Microbubbles , 1995, Investigative radiology.

[30]  A. Brayman,et al.  Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. , 1999, Ultrasound in medicine & biology.

[31]  T C Skalak,et al.  Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and Its Local Effects on Tissue. , 1998, Circulation.

[32]  G. Schmid-Schönbein,et al.  Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation: microvascular mechanisms for persistent tissue echo enhancement. , 1999, Journal of the American College of Cardiology.

[33]  J D Thomas,et al.  Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. , 2000, Journal of the American College of Cardiology.

[34]  D. Miller,et al.  The relationship of scattered subharmonic, 3.3-MHz fundamental and second harmonic signals to damage of monolayer cells by ultrasonically activated Albunex. , 1998, The Journal of the Acoustical Society of America.

[35]  D. Miller,et al.  Diagnostic Ultrasound Activation of Contrast Agent Gas Bodies Induces Capillary Rupture in Mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.